SEMNUR PHARMACEUTICALS INC C/WTS 22/09/2030(TO PUR COM)REV SPLT (SMNRW)
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- --
- Volume
- --
- Turnover
- --
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- --
- Turnover Ratio
- --
- 52wk Low
- --
- Float Mkt Cap
- --
- Market Cap
- --
- P/ETTM
- --
- P/EDynamic
- --
- P/EStatic
- --
- EPSTTM
- --
- EPSDynamic
- --
- EPSStatic
- --
- BVPS
- --
- P/B
- --
- Circulating Supply
- --
- Dividend YieldTTM
- --
- DividendTTM
- --
- Shares
- --
- Min lot size
- --
- Currency
- --
News
- Tip Ranks · Mar 17 at 08:29 PM
Semnur Pharmaceuticals Announces CEO Transition and Leadership Changes
- TradingView · Mar 17 at 08:23 PM
Semnur appoints Henry Ji as CEO & President; Jaisim Shah retires
- Earnings Watch · Feb 27 at 09:19 PM
SEMNUR PHARMACEUTICALS INC C/WTS 22/09/2030(TO PUR COM) REV SPLT | 10-K: FY2025 Revenue: USD 0
- Earnings Watch · Nov 12, 2025 at 09:18 PM
SEMNUR PHARMACEUTICALS INC C/WTS 22/09/2030(TO PUR COM) REV SPLT | 10-Q: FY2025 Q3 Revenue: USD 0
- Earnings Watch · Aug 15, 2025 at 11:51 AM
DENALI CAPITAL ACQUISITION CORP C/WTS 28/03/2027(TO PUR COM) | 10-Q: FY2025 Q2 EPS: USD -0.15
